UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
|
|
|
| (Check
One): |
|
☒ Form 10-K
☐ Form 20-F
☐ Form 11-K
☐ Form 10-Q
☐ Form 10-D
☐ Form N-CEN ☐ Form N-CSR
|
|
|
|
|
For Period Ended: December 31, 2021 |
|
|
|
|
☐ Transition Report on Form
10-K |
|
|
|
|
☐ Transition Report on Form
20-F |
|
|
|
|
☐ Transition Report on Form
11-K |
|
|
|
|
☐ Transition Report on Form
10-K |
|
|
|
|
For the Transition Period Ended:
|
|
|
|
|
Read Instructions (on back page) Before Preparing
Form. Please Print or Type.
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY
THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED
HEREIN.
|
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
N/A
PART I — REGISTRANT INFORMATION
Alpha Healthcare Acquisition Corp. III
Full Name of Registrant:
Former Name
if Applicable: N/A
1177 Avenue of the Americas, 5th Floor
Address of Principal Executive Office
(Street and Number):
New York, New York, 10036
City, State and Zip Code:
PART II — RULES 12b-25(b) AND
(c)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to
Rule 12b-25(b), the following
should be completed (Check box if appropriate)
|
|
|
|
|
|
☒ |
|
(a) |
|
The reason described in reasonable detail in Part
III of this form could not be eliminated without unreasonable
effort or expense; |
| |
(b) |
|
The subject annual report, semi-annual report,
transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or
Form N-CSR, or
portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or subject
distribution report on Form 10-D, or portion
thereof, will be filed on or before the fifth calendar day
following the prescribed due date; and |
| |
(c) |
|
The accountant’s statement or other exhibit
required by Rule 12b-25(c) has been
attached if applicable. |
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR,
or the transition
report or portion thereof, could not be filed within the prescribed
time period.
Alpha Healthcare Acquisition Corp. III (the “Company”) has
determined that it is unable, without unreasonable effort or
expense, to file its Annual Report on Form 10-K for the fiscal year
ended December 31, 2021 (the “Annual Report”) by the
prescribed due date for the reasons described below.
The Company requires additional time to complete its final review
of its financial statements and other disclosures in the Annual
Report. Furthermore, the Company’s certifying auditors have not had
the opportunity to complete their required year-end audit to be included in the
Annual Report. The Company is working diligently to complete the
Annual Report and the Company currently expects to file its Annual
Report on Form 10-K for the
fiscal period ended December 31, 2021 within the fifteen-day extension period provided
under Rule 12b-25 of the
Securities Exchange Act of 1934, as amended.
PART IV — OTHER INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
|
|
|
Name and telephone number of person
to contact in regard to this notification: |
|
|
|
|
|
|
|
|
|
|
|
Patrick A. Sturgeon |
|
|
|
(646) |
|
|
|
494-3296 |
|
|
|
|
(Name) |
|
|
|
(Area Code) |
|
|
|
(Telephone Number) |
|
|
|
| (2) |
|
|
|
Have all other periodic reports
required under Section 13 or 15(d) of the Securities Exchange
Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed? If
answer is no, identify
report(s). ☒ Yes ☐ No |
|
|
|
|
|
|
|
|
|
|
|
| (3) |
|
|
|
Is it anticipated that any
significant change in results of operations from the corresponding
period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion
thereof? ☐ Yes ☒ No |
|
|
|
|
|
|
|
If so, attach an explanation of the
anticipated change, both narratively and quantitatively, and, if
appropriate, state the reasons why a reasonable estimate of the
results cannot be made. |
Alpha Healthcare Acquisition Corp. III
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
| Date: |
|
March 31, 2022 |
|
|
|
By: |
|
/s/ Patrick A. Sturgeon
|
|
|
|
|
|
|
|
|
Name: |
|
Patrick A. Sturgeon |
|
|
|
|
|
|
|
|
Title: |
|
Chief Financial Officer |